Levoxyl®- Home

Educational Link to Third Party Website

American Thyroid Association
Clinical Thyroidology

The link on this page will take you to an external web site that is not endorsed by King Pharmaceuticals^®, Inc. This link leads to information located on servers that are beyond the control of King.

WARNING: Thyroid hormones, including Levoxyl^®, either alone or together with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In patients with a normal functioning thyroid gland, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may provide serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic based weight loss drugs.

Levoxyl^® is indicated for thyroid hormone replacement or supplemental therapy for hypothyroidism. Levoxyl^® is contraindicated in patients with untreated thyrotoxicosis, acute myocardial infarction, uncorrected adrenal insufficiency, or hypersensitivity to any of its inactive ingredients. Levoxyl^® is protected by U.S. Patent Number 6,555,581

Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdose. Use with caution in patients with cardiovascular disease.

For a full list of adverse reactions, please see full prescribing information.

©2001-2008 King Pharmaceuticals,^® Inc., 501 Fifth Street, Bristol, TN 37620. All rights reserved.
Levoxyl^® is a registered trademark of King Pharmaceuticals Research and Development, Inc.
Accudose is a registered trademark of Monarch Pharmaceuticals,^® Inc.
Monarch Pharmaceuticals^® and King Pharmaceuticals Research and Development are wholly owned subsidiaries of King Pharmaceuticals,^® Inc.